Amalgamated Bank Tyra Biosciences, Inc. Transaction History
Amalgamated Bank
- $13.6 Billion
- Q3 2025
A detailed history of Amalgamated Bank transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 701 shares of TYRA stock, worth $10,206. This represents 0.0% of its overall portfolio holdings.
Number of Shares
701
Previous 701
-0.0%
Holding current value
$10,206
Previous $6,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding TYRA
# of Institutions
123Shares Held
59.9MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA12.2MShares$178 Million2.55% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$59.4 Million95.15% of portfolio
-
Nextech Invest Ag4.06MShares$59.1 Million10.51% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$59.1 Million7.35% of portfolio
-
Bvf Inc San Francisco, CA3.94MShares$57.4 Million1.48% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $611M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...